Randomized trial demonstrates improved insulin output in obese rats with nitric oxide-lowering treatments, suggesting new therapeutic avenues.
Key Points
This research aims to understand how nitric oxide affects insulin secretion and beta cell function in the context of obesity-induced diabetes.
Prediabetic Zucker diabetic fatty rats were used to assess insulin output and nitric oxide production.
Normal and prediabetic islets were cultured with free fatty acids to analyze nitric oxide and insulin release.
In vivo treatments with nicotinamide or aminoguanidine were applied to evaluate their effects on insulin secretion and iNOS expression.
In prediabetic ZDF islets, FFA increased nitric oxide production by fourfold, correlated with reduced insulin secretion. Effectiveness of nicotinamide and aminoguanidine in lowering NO was demonstrated, leading to improved insulin output.
Treatment with nitric oxide-lowering agents significantly prevented beta cell dysfunction and hyperglycemia in prediabetic ZDF rats.